lobbying_activities: 833293

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
833293	5b3b49c0-0e52-481f-8f22-21af8deff17a	Q3	BUCHANAN INGERSOLL & ROONEY PC	55291	SHIRE PHARMACEUTICALS INC	2009	third_quarter	PHA	Pathway for follow-on biologics; orphan drugs, healthcare reform; DEA quota.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2009-10-16T16:38:20-04:00